DE3686575T2 - Pseudomonsaeure, beziehungsweise deren salze oder ester und ein corticosteroid enthaltendes, topisches arzneimittel. - Google Patents

Pseudomonsaeure, beziehungsweise deren salze oder ester und ein corticosteroid enthaltendes, topisches arzneimittel.

Info

Publication number
DE3686575T2
DE3686575T2 DE8686309668T DE3686575T DE3686575T2 DE 3686575 T2 DE3686575 T2 DE 3686575T2 DE 8686309668 T DE8686309668 T DE 8686309668T DE 3686575 T DE3686575 T DE 3686575T DE 3686575 T2 DE3686575 T2 DE 3686575T2
Authority
DE
Germany
Prior art keywords
esters
salts
relationship
medicine containing
pseudomonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686309668T
Other languages
English (en)
Other versions
DE3686575D1 (de
Inventor
Norman Andrew Orr
Michael John Greenway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of DE3686575D1 publication Critical patent/DE3686575D1/de
Application granted granted Critical
Publication of DE3686575T2 publication Critical patent/DE3686575T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8686309668T 1985-12-13 1986-12-11 Pseudomonsaeure, beziehungsweise deren salze oder ester und ein corticosteroid enthaltendes, topisches arzneimittel. Expired - Fee Related DE3686575T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858530796A GB8530796D0 (en) 1985-12-13 1985-12-13 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
DE3686575D1 DE3686575D1 (de) 1992-10-01
DE3686575T2 true DE3686575T2 (de) 1993-01-21

Family

ID=10589739

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686309668T Expired - Fee Related DE3686575T2 (de) 1985-12-13 1986-12-11 Pseudomonsaeure, beziehungsweise deren salze oder ester und ein corticosteroid enthaltendes, topisches arzneimittel.

Country Status (5)

Country Link
US (1) US4879287A (de)
EP (1) EP0231621B1 (de)
JP (1) JPH0784382B2 (de)
DE (1) DE3686575T2 (de)
GB (1) GB8530796D0 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221853B1 (hu) * 1993-10-22 2003-02-28 Smithkline Beecham Corporation Krémalapú kompozíciók és eljárás azok előállítására
US5496812A (en) * 1994-04-29 1996-03-05 Platt; Chris E. Topical preparation of tolnaftate and hydrocortisone to treat fungal infections of the skin
GB9507825D0 (en) * 1995-04-18 1995-05-31 Wet Pieter M De Method of treatment
GB9616208D0 (en) 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
WO1998014189A1 (en) * 1996-10-01 1998-04-09 Smithkline Beecham Corporation Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
CN1203184C (zh) 1999-02-03 2005-05-25 拜奥盖尔药厂有限公司 经微生物学方法制备假单胞菌酸a抗生素的方法
US6645473B2 (en) 2000-07-24 2003-11-11 Diana L. Hauan Combination tanning and antifungal topical system for treating tinea versicolor
HUP0500797A2 (en) * 2001-06-21 2007-06-28 Biogal Gyogyszergyar Metabolic controlled fermentation process for pseudomonic acid production
EP1455769A4 (de) 2001-12-28 2004-09-22 Biogal Gyogyszergyar Verfahren zur herstellung von kristallinem und amorphem mupirocin-calcium
US6964836B2 (en) * 2002-03-15 2005-11-15 Eastman Kodak Company Photosensitive microcapsules containing a synthetic viscosity modifier in the continuous phase
US20050123576A1 (en) * 2003-12-03 2005-06-09 Ilana Lavon Mupirocin compositions for topical use, an improved process of making same and methods of using same
CA2560984A1 (en) * 2004-06-01 2005-12-15 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Process for preparation of amorphous form of a drug
MXPA05009381A (es) 2005-09-02 2007-03-01 Fernando Ahumada Ayala Preparaciones para el cuidado de la piel que contienen mupirocina y dipropionato de betametasona.
MXPA06008988A (es) * 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
US20110207768A1 (en) * 2010-02-24 2011-08-25 Quadrx Pharmaceuticals Pharmaceutical combination of antibacterial and antifungal cream
EP2444067A1 (de) * 2010-10-20 2012-04-25 Laboratorios Ojer Pharma S.L. Wasserfreies Gel enthaltend Muciprocin
DE102012215511A1 (de) 2012-08-31 2014-06-12 Schülke & Mayr GmbH Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung
RU2019121559A (ru) * 2016-12-11 2021-01-14 Синерджи Дерматолоджи Лтд. Композиции, содержащие сульфатированные полисахариды

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB894424A (en) * 1959-07-30 1962-04-18 Upjohn Co Pharmaceutical compositions for topical application comprising steroids
US3178345A (en) * 1964-01-20 1965-04-13 Upjohn Co Topical steroid composition
GB1395907A (en) * 1971-06-12 1975-05-29 Beecham Group Ltd Antibiotics
US4013792A (en) * 1974-04-11 1977-03-22 Warner-Lambert Company Process for the production of base for topical steroids
GB1577730A (en) * 1976-10-23 1980-10-29 Beecham Group Ltd Treatment of infections with pseudomonicacid salts or esters thereof
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
JPS59501159A (ja) * 1982-06-24 1984-07-05 スミス、ロバ−ト・アラン 薬用ゲル組成物
GB8313035D0 (en) * 1983-05-12 1983-06-15 Beecham Group Plc Compound
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
GB2148116B (en) * 1983-10-27 1986-07-30 Ciba Geigy Ag Topical steroid preparations
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
DE3686575D1 (de) 1992-10-01
EP0231621A2 (de) 1987-08-12
JPH0784382B2 (ja) 1995-09-13
EP0231621B1 (de) 1992-08-26
GB8530796D0 (en) 1986-01-22
EP0231621A3 (en) 1987-11-25
JPS62164623A (ja) 1987-07-21
US4879287A (en) 1989-11-07

Similar Documents

Publication Publication Date Title
DE3686575T2 (de) Pseudomonsaeure, beziehungsweise deren salze oder ester und ein corticosteroid enthaltendes, topisches arzneimittel.
ATE135713T1 (de) Hyaluronsäureester und ihre salze.
MX9203170A (es) Composicion farmaceutica con actividad analgesica.
DE3778132D1 (de) 2-beta-substituierte methylpenicillansaeure-derivate und deren salze und ester.
CY1443A (en) Pharmaceutical preparations for topical application which contain salts jof alkanecarboxylic acids,novel carboxylic acid salts and the production thereof
DE3669882D1 (de) 2-zyanakrylsaeureester enthaltende zusammensetzung.
NL192343B (nl) 17Ó-gesubstitueerde androsta-(1,)4-(di)een-3-on-17ß-carbonzuurverbindingen met een ontstekingswerende werkzaamheid en farmaceutische preparaten, die deze verbindingen bevatten.
AU605123B2 (en) Tetrazolyl, benzoic acid and benzoic acid ester derivatives having anti-inflammatory and analgesic activity
DE3575929D1 (de) Methylenbisphosphonsaeure-derivate, deren herstellung und arzneimittel.
DE3671913D1 (de) Waessrige klebstoffe und deren verwendung.
NL8601011A (nl) 7-amino-3-propenylcefalosporanzuur en esters daarvan.
NL192741B (nl) Oxazafosforin-4-thioalkaanzuurverbindingen en farmaceutisch preparaat met antineoplastische eigenschappen.
ATE42751T1 (de) Carboxylsaeureesterderivate von deglucoteicoplanin.
DE3579715D1 (de) Substituierte iminophenole-(azacycloalk-2-yl) und deren ester.
DK165880C (da) Androstan-17beta-carboxylsyreestere, fremgangsmaade til fremstilling heraf samt farmaceutisk praeparat indeholdende samme
DE3873167T2 (de) Thiazolidin-4-on-derivate und deren saeure-additionssalze.
DE69020619D1 (de) 2-Halogenpyridin-6-sulfonsäure und deren Salze.
ATE32882T1 (de) Phenylnonatetraensaeurederivate, ihre herstellung und pharmazeutische praeparate mit diesen derivaten.
DE3675722D1 (de) 4-alkoxy-3-pyrrolin-2-on-1-yl-essigsaeurealkyl- bzw. -benzylester sowie deren herstellung.
DE3673068D1 (de) Alpha-fluoracrylsaeureester und deren polymere.
DE3689702D1 (de) Dihydrolysergsäureester.
DE3683960D1 (de) Kristalliner hydroxyphenylpropionsaeureester und seine herstellung.
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
ATE50262T1 (de) Methylenbisphosphonsaeure-derivate, deren herstellung und arzneimittel.
ATE78821T1 (de) Thiazolidin-4-on-derivate und deren saeureadditionssalze.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PFIZER, INC. (N.D.GES.D. STAATES DELAWARE), NEW YO

8339 Ceased/non-payment of the annual fee